logo conferre20 years

Σύμφωνα με τα κριτήρια της UEMS - EACCME χορηγούνται 16 μόρια Συνεχιζόμενης Ιατρικής Εκπαίδευσης (CME-CPD credits)
Friday, January 13, 2023
16.30 - 17.00 Εισαγωγή • Introduction
G. Mantzaris
17:00 - 18.30 Diagnostic Modalities with Clinical Applications
Chair: M. Tzouvala, S. Potamianos
17:00-17:15 Crohn’s Disease Capsule Endoscopy
N. Viazis
17:15-17:30 Intestinal US
GFiorino italy
17:30-17:45 Confocal endomicroscopy: where do we stand?
R. Atreya germany
17:45-18:00 Can we harvest new bio-markers in the microbiome?
F. Magro portugal
18:00-18:15 Application of artificial Intelligence in the field of IBD
UKopylov israel
18:15-18:30 Discussion
18:30 - 18:50 State of the art lecture
Chair: G. Bamias, N. Viazis
  TDM for biologic therapy in IBD: A Journey from the Dept of Gastroenterology, Evangelismos Hospital to Leuven and Harvard
K. Papamichail usa
 18:50-19.05 Χαιρετισμοί – Welcome Messages

Η ΕΟΜΙΦΝΕ τιμά τον Γεράσιμο Μάντζαρη/ The Hellenic Society for the study of IBD honours Dr. Gerassimos Mantzaris
Προεδρείο: Γ. Μπάμιας, Ν. Βιάζης/ Chair: G. Bamias, N. Viazis


Gerassimos Mantzaris: a journey of challenges and achievements through life and medicine
N. Viazis

  A short review of the history of IBD
G. Mantzaris
20:00 Welcome Reception/ Cocktail
Saturday, January 14, 2023
09:00 - 10:30

A Critical Review of the Past and Present Immunomodulating and Biologic Treatments: where do we stand today?

Chair: D. Christodoulou, D. Karagiannis
09:00-09:15 Thiopurines
P. Gionchetti italy
09:15-09:30 Anti-TNFα
G. Van Assche belgium
09:30-09:45 Anti-integrins
R. Eliakim israel
09:45-10:00 Leukocytapheresis
E. Domènech spain
10:00-10:15 Anti-IL12/IL23/p40
M. Allez france
10:15-10:30 Discussion
10.30 - 11:00 State of the Art Lecture
Chair: O. Giouleme, S. Manolakopoulos
  Pouch related pathology: treatment and lessons on IBD
I. Dotan israel
11:00 - 11:30 Διάλειμμα καφέ/ Coffee break
11.30 - 13:30 Novel biologics, small molecules, and future therapies: Great Expectations, or?
Chair: E. Zampeli, G. Michalopoulos
11:30-11:50 Αnti-IL23/p19
S. Ben Horin israel
11:50-12:10 SP1 modulators
J. Lindsay uk
12:10-12:30 Pan-JAK/JAK-1 inhibitors
B. Siegmund germany
12:30-12:50 Targeting the microbiome
PSeksik france
12:50-13:10 Can we restore intestinal damage
G. Bamias
13:10-13:30 Discussion
13:30 - 14:30 State of the Art Lecture
New therapeutic strategies and new end-points in RCTs
Chair: K. Karmiris, D. Polymeros
13:30-14:00 Determining Therapeutic Goals for Treat-to-Target strategies in IBD: What new goals does STRIDE II bring?
A. Dignass germany
14:00-14:30 A critical analysis of the IOIBD proposed new end-points for Disease Modifying Trials in IBD
G. Rogler switserland
14:30 - 15:30 Ελαφρύ Γεύμα/ Light Lunch
15.30 - 16.00 State of the Art Lecture
Chair: M. Kontogianni, M. Gazouli
  Microbiota-targeted dietary interventions in IBD patients
L. Godny israel
16.00 - 16:30 State of the Art Lecture
Chair: S. Michopoulos, A. Theodoropoulou
  Therapeutic strategies for the prevention of post-operative recurrence of Crohn’s disease
M. Allez france
16:30 - 18:00

Case-based discussion Ι: short cases – short answers/comments
Clinical dilemmas in the practice of IBD

Chair: G. Bamias, I. Papakonstantinou
Presenter: G. Mantzaris

Discussants: A. D’ Hoore belgium, MAllez france, Gert Van Assche belgiumSBen Horin israel, I. Dotan israel, G. Fiorino italy, BSiegmund germany, Κ. Papamichail usa

IFX-rescue therapy for iv steroid-refractory UC patient. Empirical? Accelerated? Proactive TDM?

Monitoring the CD patient on maintenance anti-TNF therapy: biomarkers or Proactive TDM?

Novel combination therapies: which? for whom? when?

My chosen biologic MoA: when effectiveness matters/when safety matters

When and how can I stop biologic therapy?

Early surgery or medical therapy for limited terminal ileitis/ ielocolitis?

18:00- 18:15 Διάλειμμα καφέ/ Coffee break
18:15 - 19:30

Case-based discussion ΙI: short cases – short answers/comments
Application of new treatment goals in the real world

Chair: I. Koutroubakis, K. Katsanos
Presenter: G. Mantzaris

Discussants: R. Atreya germany, A. Dignass germany, A. Eliakim israel, P. Gionchetti italy, J. Lindsay uk, F. Magro portugal, G. Rogler switserland

→ Should I strive for Endoscopic or Transmural healing in Crohn disease?

→ Can I tolerate near complete endoscopic healing in CD?

→ Is histologic healing in CD cost-effective? and if yes, how to assess?

→ Endoscopic healing in UC: Mayo 0 or Mayo 1?

→ Should I strive for histologic remission in UC?

→ Can the current therapies achieve these robust end points? What are the unmet needs

How to incorporate patients views in end-points for RCTs and in real-life practice?

19:30 - 20:00

Discussion with the Mentors
IBD therapies: Where did we start and where we are heading to?

Chair: G. Mantzaris, I. Koutroubakis, I. Triantafyllidis
Discussants: D. P. Jewell uk, J. Schölmerich germany

A review of the history and thoughts for the future treatments of IBD including unmet needs for a holistic approach to the treatment of IBD
Sunday, January 15, 2023
09:00 - 09:45

Νέα δεδομένα για τη θεραπεία λοιμώξεων στις ΙΦΝΕ/ Update in the management of infections in IBD

Προεδρείο: Β. Παπασταμόπουλος, Ι. Βλαχογιαννάκος/ Chairs: V. Papastamopoulos, I. Vlachogiannakos

C. difficile
ΟΓιουλεμέ/ O. Giouleme


ΠΚαρατζάςP. Karatzas


Μ. - Λ. Χατζηνικολάου/ M. - L Chatzinicolaou

09:45 - 10:45

Εξωεντερικές εκδηλώσεις στις ΙΦΝΕ. Red Flags!/ Extraintestinal manifestations in IBD: Red flags!

Προεδρείο: Γ. Παπαθεοδωρίδης, Ε. Τσιρώνη/ Chairs: G. Papatheodoridis, E. Tsironi

Πότε θα χρειαστώ Ρευματολόγο;/ When do I need a Rheumatologist?
Δ. ΒασιλόπουλοςD. Vassilopoulos


Πότε θα χρειαστώ Δερματολόγο;/ When do I need a Dermatologist?
ΗΝικολαΐδουE. Nicolaidou


Πότε θα χρειαστώ Οφθαλμίατρο;/ When do I need an Ophthalmologist?
ΝΜαρκομιχελάκηςN. Markomichelakis


Πώς θα αντιμετωπίσω τις παράδοξες φλεγμονές;/ How should I manage paradoxical inflammation?
Κ. Σουφλέρης / K. Soufleris

10:45 - 11:15 Διάλειμμα καφέ/ Coffee break
11:15 - 12:15 State of the Art Lectures
Chair: D. Magganas, E. Archavlis
11:15-11:45 Perianal fistulizing Crohn’s disease: to drain, to seton, to LIFT, to plug, or to cut?
I. Papaconstantinou
11:45-12:15 The role of surgery in IBD today and tomorrow
A. D'Hoore belgium
12.15 - 13.15

Ηωσινοφιλική Οισοφαγίτιδα/ Eosinophilic oesophagiotis

Προεδρείο: Α. Μαντίδης, Ε. Τσουκάλη/ Chairs: A. Mantides, E. Tsoukali

Δίαιτα;/ Diet?
ΑΚαραχάλιουA. Karachaliou


ΚΒαρυτιμιάδηςK. Varitimiadis


Τοπικά στεροειδή;/ Locally acting steroids?
ΒΠαπαστεργίου/ V. Papastergiou


Συνεχής ή επεισοδιακή θεραπεία;/ Continuous or episodic treatment?
Α. Μανωλάκης/ AManolakis  

13:15 - 14:30

Κοιλιοκάκη & Μικροσκοπική Κολίτιδα/ Coeliac disease and microscopic colitis

ΠροεδρείοΜΜελά, A. ΧρηστίδουChairs: M. Mela, A. Christidou

Μιμητές της κοιλιοκάκης/ Coeliac disease mimickers
Ν. Μάθου/ N. Mathou   


Ο διαγνωστικά οριακός ασθενής με τις συνήθεις διαγνωστικές μεθόδους: μπορεί να βοηθήσει η γενετική;/ The diagnostic borderline patient: can genetics help?
Α. Τσιρογιάννη/ ATsirogianni


Χρειάζομαι ακόμη ένα διαιτολόγο;/ Do I still need a dietician?
Δ. Καραγιάννης/ DKaragiannis


Μη διαιτητικές θεραπείες: Φως στην άκρη του τούνελ;/ Non dietetic therapies: is there light at the end of the tunnel?
Χρ. Τριάντος/ ChrTriantos


Μικροσκοπική κολίτιδα: Διαγνωστικοί και Θεραπευτικοί χειρισμοί/ Microscopic colitis: diagnostic and therapeutic interventions
ΕΖαμπέληE. Zampeli

14:15 - 14:30 Ανασκόπηση ­- Αποχαιρετισμός/ Review and Farewell


Organizing - Administrative Bureau/ Secretariat:


Conferre SA: "The Art of Bringing People Together".

  • Stavrou Niarchou Ave., Mares Position
    GR455 00 Pedini, Ioannina, GREECE
  • +30 26510 68610
  • +30 26510 68611
  • info@conferre.gr
ΓΕΜΗ: 31498929000
Certified by ISO 9001:2015
Certificate Number 00.12.0895
Αριθμός Αδείας ΕΟΤ